Loss of cis-PTase function in the liver promotes a highly penetrant form of fatty liver disease that rapidly transitions to hepatocellular carcinoma.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
15 Nov 2023
Historique:
pubmed: 28 11 2023
medline: 28 11 2023
entrez: 28 11 2023
Statut: epublish

Résumé

Obesity-linked fatty liver is a significant risk factor for hepatocellular carcinoma (HCC)

Identifiants

pubmed: 38014178
doi: 10.1101/2023.11.13.566870
pmc: PMC10680637
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIDDK NIH HHS
ID : K01 DK124441
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK125492
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL139945
Pays : United States

Références

Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
J Lipid Res. 2013 Dec;54(12):3516-22
pubmed: 24078709
Am J Hum Genet. 2011 Feb 11;88(2):207-15
pubmed: 21295282
Nature. 2021 Apr;592(7854):450-456
pubmed: 33762733
Cancer Cell. 2017 Dec 11;32(6):807-823.e12
pubmed: 29232555
Am J Physiol. 1994 Sep;267(3 Pt 1):G338-49
pubmed: 7943230
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65
pubmed: 24080776
iScience. 2020 Oct 15;23(11):101690
pubmed: 33163943
Sci Transl Med. 2019 Nov 27;11(520):
pubmed: 31776293
Trends Cancer. 2020 Sep;6(9):757-766
pubmed: 32381431
Hepatology. 2016 Nov;64(5):1559-1576
pubmed: 27480224
World J Gastroenterol. 2019 Nov 21;25(43):6440-6450
pubmed: 31798280
BMC Genomics. 2019 Aug 30;20(1):685
pubmed: 31470794
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Cell. 2018 Nov 15;175(5):1289-1306.e20
pubmed: 30454647
J Biol Chem. 2021 Jan-Jun;296:100624
pubmed: 33812996
Brain. 2022 Mar 29;145(1):208-223
pubmed: 34382076
J Hepatol. 2022 Nov;77(5):1373-1385
pubmed: 35750138
Cell. 2010 Mar 19;140(6):900-17
pubmed: 20303879
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):411-428
pubmed: 31028350
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20794-20802
pubmed: 32817466
Chem Phys Lipids. 1987 Nov-Dec;45(2-4):117-42
pubmed: 3319224
J Hepatol. 2018 Aug;69(2):385-395
pubmed: 29572095
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Oncotarget. 2015 Jan 20;6(2):755-70
pubmed: 25605237
Cancer Cell. 2014 Oct 13;26(4):549-64
pubmed: 25314080
J Clin Invest. 2004 Jul;114(2):147-52
pubmed: 15254578
Cell Metab. 2014 Sep 2;20(3):448-57
pubmed: 25066056
Sci Rep. 2022 Jul 19;12(1):12330
pubmed: 35853969
EMBO Rep. 2016 Feb;17(2):167-77
pubmed: 26755743
Mol Cancer Res. 2021 Nov;19(11):1868-1877
pubmed: 34380744
J Biol Chem. 2016 Aug 26;291(35):18582-90
pubmed: 27402831
iScience. 2020 Jun 26;23(6):101198
pubmed: 32526701
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2
pubmed: 23041539
Nat Metab. 2022 Dec;4(12):1632-1649
pubmed: 36539621
Cell. 2010 Jan 22;140(2):197-208
pubmed: 20141834
BMC Gastroenterol. 2016 Jun 13;16(1):61
pubmed: 27296438
Hepatology. 2017 Apr;65(4):1181-1195
pubmed: 27981604
Trends Cancer. 2021 Jan;7(1):29-36
pubmed: 32917550
Clin Chim Acta. 1992 Jun 30;208(3):149-71
pubmed: 1499135
J Hepatol. 2016 Sep;65(3):579-88
pubmed: 27261415
N Engl J Med. 2011 Sep 22;365(12):1118-27
pubmed: 21992124
Cancer Cell. 2014 Sep 8;26(3):331-343
pubmed: 25132496
J Clin Invest. 2004 Jun;113(12):1774-83
pubmed: 15199412
J Med Chem. 2015 Sep 24;58(18):7173-85
pubmed: 26349027
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Aging (Albany NY). 2022 Mar 7;14(5):2025-2046
pubmed: 35255004
Clin Cancer Res. 2019 Aug 1;25(15):4701-4711
pubmed: 31068370
J Clin Invest. 2021 Jul 13;:
pubmed: 34255741

Auteurs

Abhishek K Singh (AK)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Balkrishna Chaube (B)

Department of Comparative Medicine, Yale Center for Molecular and Systems Metabolism and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.

Kathryn M Citrin (KM)

Department of Comparative Medicine, Yale Center for Molecular and Systems Metabolism and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.

Joseph Wayne Fowler (JW)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Sungwoon Lee (S)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Jonatas Catarino (J)

Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.

James Knight (J)

Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

Sarah Lowery (S)

Chemistry Research Building, Yale University, New Haven, CT, USA.

Sonal Shree (S)

Molecular Biophysics & Biochemistry, Yale University, New Haven, CT, USA.

Nabil Boutagy (N)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Inmaculada Ruz-Maldonado (I)

Department of Comparative Medicine, Yale Center for Molecular and Systems Metabolism and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.

Kathy Harry (K)

Department of Internal Medicine, Yale University, New Haven, CT, USA.

Marya Shanabrough (M)

Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.

Trenton Thomas Ross (TT)

Internal Medicine Research Unit (IMRU), Pfizer, Cambridge, MA, USA.

Stacy Malaker (S)

Chemistry Research Building, Yale University, New Haven, CT, USA.

Yajaira Suárez (Y)

Department of Comparative Medicine, Yale Center for Molecular and Systems Metabolism and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.
Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

Carlos Fernández-Hernando (C)

Department of Comparative Medicine, Yale Center for Molecular and Systems Metabolism and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.
Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

Kariona Grabinska (K)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

William C Sessa (WC)

Department of Pharmacology, and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut, 06520, USA.

Classifications MeSH